Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2010 1
2011 3
2012 3
2014 1
2015 4
2016 2
2017 1
2018 3
2019 5
2020 5
2021 5
2022 2
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Should Dehydroepiandrosterone Be Administered to Women?
Wierman ME, Kiseljak-Vassiliades K. Wierman ME, et al. Among authors: kiseljak vassiliades k. J Clin Endocrinol Metab. 2022 May 17;107(6):1679-1685. doi: 10.1210/clinem/dgac130. J Clin Endocrinol Metab. 2022. PMID: 35254428 Free PMC article. Review.
Preclinical Models of Adrenocortical Cancer.
Sedlack AJH, Hatfield SJ, Kumar S, Arakawa Y, Roper N, Sun NY, Nilubol N, Kiseljak-Vassiliades K, Hoang CD, Bergsland EK, Hernandez JM, Pommier Y, Del Rivero J. Sedlack AJH, et al. Among authors: kiseljak vassiliades k. Cancers (Basel). 2023 May 23;15(11):2873. doi: 10.3390/cancers15112873. Cancers (Basel). 2023. PMID: 37296836 Free PMC article. Review.
Senescence-induced immune remodeling facilitates metastatic adrenal cancer in a sex-dimorphic manner.
Warde KM, Smith LJ, Liu L, Stubben CJ, Lohman BK, Willett PW, Ammer JL, Castaneda-Hernandez G, Imodoye SO, Zhang C, Jones KD, Converso-Baran K, Ekiz HA, Barry M, Clay MR, Kiseljak-Vassiliades K, Giordano TJ, Hammer GD, Basham KJ. Warde KM, et al. Among authors: kiseljak vassiliades k. Nat Aging. 2023 Jul;3(7):846-865. doi: 10.1038/s43587-023-00420-2. Epub 2023 May 25. Nat Aging. 2023. PMID: 37231196
FSCN1 as a new druggable target in adrenocortical carcinoma.
Ruggiero C, Tamburello M, Rossini E, Zini S, Durand N, Cantini G, Cioppi F, Hantel C, Kiseljak-Vassiliades K, Wierman ME, Landwehr LS, Weigand I, Kurlbaum M, Zizioli D, Turtoi A, Yang S, Berruti A, Luconi M, Sigala S, Lalli E. Ruggiero C, et al. Among authors: kiseljak vassiliades k. Int J Cancer. 2023 Jul 1;153(1):210-223. doi: 10.1002/ijc.34526. Epub 2023 Mar 31. Int J Cancer. 2023. PMID: 36971100
The Immunotherapy Landscape in Adrenocortical Cancer.
Pegna GJ, Roper N, Kaplan RN, Bergsland E, Kiseljak-Vassiliades K, Habra MA, Pommier Y, Del Rivero J. Pegna GJ, et al. Among authors: kiseljak vassiliades k. Cancers (Basel). 2021 May 28;13(11):2660. doi: 10.3390/cancers13112660. Cancers (Basel). 2021. PMID: 34071333 Free PMC article. Review.
Update on in-vivo preclinical research models in adrenocortical carcinoma.
Kar A, Wierman ME, Kiseljak-Vassiliades K. Kar A, et al. Among authors: kiseljak vassiliades k. Curr Opin Endocrinol Diabetes Obes. 2020 Jun;27(3):170-176. doi: 10.1097/MED.0000000000000543. Curr Opin Endocrinol Diabetes Obes. 2020. PMID: 32304391 Free PMC article. Review.
PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma.
Warmington E, Smith G, Chortis V, Liang R, Lippert J, Steinhauer S, Landwehr LS, Hantel C, Kiseljak-Vassiliades K, Wierman ME, Altieri B, Foster PA, Ronchi CL. Warmington E, et al. Among authors: kiseljak vassiliades k. Endocr Connect. 2023 Dec 14;13(1):e230403. doi: 10.1530/EC-23-0403. Print 2024 Jan 1. Endocr Connect. 2023. PMID: 37992487 Free PMC article.
Clinical implications of growth hormone-secreting tumor subtypes.
Kiseljak-Vassiliades K, Shafi S, Kerr JM, Phang TL, Kleinschmidt-DeMasters BK, Wierman ME. Kiseljak-Vassiliades K, et al. Endocrine. 2012 Aug;42(1):18-28. doi: 10.1007/s12020-012-9660-9. Epub 2012 Mar 21. Endocrine. 2012. PMID: 22434413 Review.
40 results